SCHEMBL9541567

SCHEMBL9541567

CN1C(=O)Nc2ccc([N+](=O)[O-])cc2C1(O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.54
ALDH1A1 P00352 2/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.48
MAPT P10636 1/20 0.47
MDM2 Q00987 1/20 0.45
ALPL P05186 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PGR P06401 1/20 0.41
SNCA P37840 1/20 0.40
CAPN9 O14815 1/20 0.40
CASP3 P42574 1/20 0.40
BRD4 O60885 1/20 0.39
LMNA P02545 1/20 0.39
ACHE P22303 1/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11392587 0.80 AKR1B1 (0.51) AKR1B1ALDH1A1L3MBTL1MAPTALPL
SCHEMBL9540134 0.80 AKR1B1 (0.51) AKR1B1ALDH1A1CYP2C19MAPTKMT2A
SCHEMBL9541565 0.80 AKR1B1 (0.51) AKR1B1MAPTMDM2MEN1KMT2A
SCHEMBL9539832 0.79 AKR1B1 (0.51) AKR1B1ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL28227469 0.77 ALDH1A1 (0.57) AKR1B1ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL14691602 0.71 SNCA (0.51) AKR1B1ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL11842027 0.71 ALPL (0.45) AKR1B1ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL11851382 0.71 NPC1 (0.49) AKR1B1ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL10775957 0.70 AKR1B1 (1.00) AKR1B1
SCHEMBL14691284 0.69 SNCA (0.55) AKR1B1ALDH1A1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1071917-A Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist MERCK & CO INC (US) 1993-05-12 CN disclosed
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed